Device Exec Charged With COVID-19 Securities Fraud
The CEO allegedly falsely told investors that the company was closing in on FDA clearance for a rapid-detection COVID-19 test.
You may also be interested in...
Three attorneys got out their crystal balls to forecast what device industry sectors may come in for enforcement scrutiny related to the COVID-19 pandemic.
The updates reflect changes to standards on medical electrical equipment and a wide range of device types.
The sentences are the latest chapter in a long-running off-label marketing case.